InvestorsHub Logo

zzaatt

05/03/22 5:49 PM

#15262 RE: Whalatane #15257

AUPH could cut their asking price significantly ( apparently this is not an expensive drug to make ) and make $ thru higher volume ....but so far have apparently chosen not to follow that path

Maybe their internal research and projections do not support the "higher volume" thesis. I would think they're best qualified to make that judgement.